ALDRIGHETTI, LUCA ANTONIO MARIA
 Distribuzione geografica
Continente #
AS - Asia 16.051
NA - Nord America 9.250
EU - Europa 6.198
SA - Sud America 5.456
AF - Africa 350
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 18
AN - Antartide 1
Totale 37.344
Nazione #
US - Stati Uniti d'America 8.813
SG - Singapore 7.176
BR - Brasile 4.570
CN - Cina 3.757
HK - Hong Kong 2.472
SE - Svezia 1.563
VN - Vietnam 1.545
IT - Italia 1.184
RU - Federazione Russa 839
DE - Germania 663
FI - Finlandia 371
AR - Argentina 349
IE - Irlanda 298
RO - Romania 279
AT - Austria 217
GB - Regno Unito 217
EC - Ecuador 192
CA - Canada 180
IN - India 178
MX - Messico 161
ID - Indonesia 155
BD - Bangladesh 152
ZA - Sudafrica 124
NL - Olanda 112
JP - Giappone 108
PL - Polonia 96
IQ - Iraq 90
PY - Paraguay 86
CO - Colombia 83
FR - Francia 75
ES - Italia 69
TR - Turchia 65
UA - Ucraina 59
MA - Marocco 57
VE - Venezuela 54
CL - Cile 48
EG - Egitto 43
UZ - Uzbekistan 43
PK - Pakistan 42
KE - Kenya 38
LT - Lituania 37
PE - Perù 31
UY - Uruguay 30
TN - Tunisia 26
SA - Arabia Saudita 25
AE - Emirati Arabi Uniti 24
AZ - Azerbaigian 23
NP - Nepal 22
DO - Repubblica Dominicana 21
CH - Svizzera 18
DZ - Algeria 17
HN - Honduras 17
IR - Iran 16
KR - Corea 16
AU - Australia 14
BE - Belgio 14
IL - Israele 14
OM - Oman 14
KZ - Kazakistan 13
MY - Malesia 13
AL - Albania 12
JO - Giordania 12
JM - Giamaica 11
A1 - Anonimo 10
BH - Bahrain 9
NI - Nicaragua 9
SK - Slovacchia (Repubblica Slovacca) 9
TT - Trinidad e Tobago 9
TW - Taiwan 9
HU - Ungheria 8
LB - Libano 8
NO - Norvegia 8
PA - Panama 8
GT - Guatemala 7
PH - Filippine 7
XK - ???statistics.table.value.countryCode.XK??? 7
BO - Bolivia 6
AO - Angola 5
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
CI - Costa d'Avorio 5
ET - Etiopia 5
GR - Grecia 5
KG - Kirghizistan 5
LV - Lettonia 5
LY - Libia 5
MK - Macedonia 5
CG - Congo 4
GY - Guiana 4
KH - Cambogia 4
KW - Kuwait 4
LU - Lussemburgo 4
MD - Moldavia 4
PS - Palestinian Territory 4
RS - Serbia 4
TH - Thailandia 4
AM - Armenia 3
BG - Bulgaria 3
BN - Brunei Darussalam 3
BW - Botswana 3
Totale 37.275
Città #
Dallas 3.808
Singapore 3.062
Hong Kong 2.460
Shanghai 1.047
Hefei 984
Ashburn 794
Lawrence 740
Princeton 740
Ho Chi Minh City 633
Beijing 417
São Paulo 334
Hanoi 304
Dublin 296
Helsinki 296
Milan 281
Los Angeles 227
Nuremberg 221
New York 213
Moscow 188
Rio de Janeiro 147
Boardman 129
Rome 122
Munich 116
Vienna 107
Belo Horizonte 91
Brasília 90
Warsaw 86
Curitiba 74
Tokyo 74
Guayaquil 67
Campinas 66
Da Nang 66
Quito 64
Santa Clara 62
Stockholm 62
Montreal 61
Johannesburg 57
Haiphong 54
Porto Alegre 54
Biên Hòa 53
Chicago 53
Guangzhou 53
London 53
Denver 52
Brooklyn 50
Guarulhos 48
Mexico City 48
Salvador 48
Toronto 47
Cesano Boscone 46
Poplar 46
Chennai 44
Atlanta 43
Houston 43
Boston 41
Tashkent 41
Turku 38
Amsterdam 36
Orem 36
Lappeenranta 35
Fortaleza 34
Santo André 34
Frankfurt am Main 33
Phoenix 33
Recife 33
Ribeirão Preto 33
Goiânia 32
San Francisco 32
Thái Bình 32
Baghdad 31
Buenos Aires 31
Manaus 31
Jakarta 29
Nairobi 29
Seattle 28
Washington 27
Bologna 26
Council Bluffs 26
Dhaka 26
Sorocaba 26
Asunción 25
Brescia 25
Can Tho 25
Cape Town 25
Maceió 25
Naples 25
Nova Iguaçu 25
Tianjin 25
Cairo 24
Caxias do Sul 24
Juiz de Fora 24
Manchester 24
Sumaré 24
Baku 23
Hải Dương 23
São Bernardo do Campo 23
Contagem 22
Montevideo 22
Pelotas 22
Bogotá 21
Totale 20.730
Nome #
111In-octreotide SPECT in occult carcinoid tumors 1.359
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 195
[Clinical value of spleen autograft]. FT Considerazioni sul valore clinico dell'autoinnesto di milza 153
[Conservative treatment of postoperative pancreatic fistula. Role of interventional radiology]. FT Trattamento conservativo della fistola pancreatica postoperatoria. Ruolo della radiologia interventistica 144
. Il trapianto di isole pancreatiche come alternativa alla terapia sostitutiva insulinica intensiva nei pazienti affetti da diabete mellito di tipo 1: l'esperienza dell'Istituto Scientifico San Raffale di Milano 141
[Continuous 24-hour intragastric pH monitoring. A new model of interpretation]. FT La pHmetria endogastrica continua sulle 24 ore. Nuovo modello d'interpretazione 135
18 casi di incidentaloma della colecisti: analisi della casistica di un singolo centro 128
A comparison between robotic, laparoscopic and open hepatectomy: A systematic review and network meta-analysis 127
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 126
"Technological" approach versus clamp crushing technique for hepatic parenchymal transection: A comparative study 124
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 122
[Is the surgical treatment of spontaneous bacterial peritonitis still up-to-date?]. FT Trattare chirurgicamente la peritonite batterica spontanea e ancora attuale? 122
[Intestinal occlusion in cocaine-packet ingestion]. FT L'occlusione intestinale nella cocaine-packet ingestion 121
[Role of totally implantable systems for long-term vascular access in the treatment of the neoplastic patient]. FT Ruolo dei sistemi totalmente impiantabili per accesso vascolare a lungo termine nel trattamento del paziente neoplastico 119
A machine learning predictive model for recurrence of resected distal cholangiocarcinoma: Development and validation of predictive model using artificial intelligence 116
[Impact of preoperative locoregional chemotherapy with fluorodeoxyuridine on the outcome of liver resection]. FT Impatto della chemioterapia locoregionale preoperatoria con fluorodesossiuridina (FUDR) sulla chirurgia resettiva epatica 115
30 cases of "two stage hepatectomy” for liver metastases from colorectal cancer: a single centre experience 113
A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample Size 112
[Advanced age as risk factor in liver resection surgery]. FT L'eta avanzata come fattore di rischio nella chirurgia resettiva epatica 112
[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases]. FT Fattori prognostici dell'outcome a lungo termine della chirurgia resettiva epatica per metastasi da carcinoma colorettale 111
A comprehensive preoperative predictive score for post-hepatectomy liver failure after hepatocellular carcinoma resection based on patient comorbidities, tumor burden, and liver function: the CTF score 109
[Hepatic resection of metastasis of colorectal carcinoma: analysis of long-term prognostic factors of outcome]. FT Resezioni epatiche per metastasi da carcinoma colorettale: analisi dei fattori prognostici di outcome a lungo termine 103
Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin 100
[Multimodal approach to rectal carcinoma with hepatic metastasis]. FT Approccio multimodale al carcinoma del retto con metastasi epatica 99
Recommendations for laparoscopic liver resection: A report from the second international consensus conference held in morioka 98
Liver Histology Predicts Liver Regeneration and Outcome in ALPPS: Novel Findings From A Multicenter Study 95
Minimally invasive approach for liver resections in patients with hepatocellular carcinoma and Child-Pugh B cirrhosis: shifting the paradigm? Long-term Outcomes from an International Multicentre Study 94
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 91
A Prognostic Model To Predict Survival After Recurrence Among Patients With Recurrent Hepatocellular Carcinoma 87
Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions 85
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 82
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab 80
Combined hepatocellular-cholangiocarcinoma: morpho-molecular updates and considerations 77
Combined Loco-Regional and Systemic Treatment Strategies for Hepatocellular Carcinoma: From Basics to New Developments 74
Comparison of CMV reactivation after islet-kidney, pancreas-kidney or kidney alone transplantation in diabetic patients 73
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 72
Comparison between percutaneous and laparoscopic microwave ablation of hepatocellular carcinoma 72
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 71
Utilizzo combinato di dissettore ad ultrasuoni e bisturi armonico nella chirurgia resettiva epatica: esperienza su 100 resezioni epatiche 70
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib 70
Combining Laparoscopic Liver Partitioning and Simultaneous Portohepatic Venous Deprivation for Rapid Liver Hypertrophy 68
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 68
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases 68
Preoperative MRI radiomic analysis for predicting local tumor progression in colorectal liver metastases before microwave ablation 67
A “cui prodest” evaluation on the development of a minimally invasive liver surgery program: a differential benefit analysis of open and laparoscopic approach for left and right hemihepatectomies 66
Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis 65
Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma 65
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 65
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis 65
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance to human islet transplantation 65
Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience 65
Single-Center Retrospective Study Comparing Double Vein Embolization via a Trans-Jugular Approach with Liver Venous Deprivation via a Trans-Hepatic Approach 64
Predictors and Prognostic Significance of Postoperative Complications for Patients with Intrahepatic Cholangiocarcinoma 63
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab 62
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 62
Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma 62
ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study 62
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 62
The failure to rescue factor: aftermath analyses on 224 cases of perihilar cholangiocarcinoma 61
Navigator nurse implementation within a fast track program of liver resections: How to improve the healthcare service and perioperative results 61
Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US 61
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy 61
Perihilar Cholangiocarcinoma - Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers 61
Achievement of textbook outcome after hepatectomy combined with thermal ablation for colorectal liver metastases 61
A Nomogram to Predict Long-term Survival After Resection for Intrahepatic Cholangiocarcinoma An Eastern and Western Experience 60
A stepwise learning curve to define the standard for technical improvement in laparoscopic liver resections: complexity-based analysis in 1032 procedures 60
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population 59
The complication-overall survival (CompOS) risk tool predicts risk of a severe postoperative complications relative to long-term survival among patients with primary liver cancer 59
Retrospective Evaluation and Significance of Neutrophil-to-Lymphocyte Ratio Prior to and 1 month Following Microwave Ablation of Hepatocellular Carcinoma 59
Defining and predicting textbook outcomes for perihilar cholangiocarcinoma: analysis of factors improving achievement of desired postoperative outcomes 59
Caratterizzazione della omeostasi glucidica in pazienti affetti da diabete mellito di tipo 1 un anno dopo il trapianto di isole pancreatiche 59
Case-Matched Analysis of Totally Laparoscopic Versus Open Liver Resection for HCC: Short and Middle Term Results 59
ASO Author Reflections: Surgical Strategy for Perihilar Cholangiocarcinoma 58
An attempt to establish and apply global benchmarks for liver resection of malignant hepatic tumors 58
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 58
ASO Author Reflections: Cirrhosis and Severity of Cirrhosis Negatively Affects the Outcomes of Laparoscopic and Robotic Major Liver Resections for Primary Liver Malignancies 58
ASO Author Reflections: Hypertrophic Techniques Have an Impact on the Complexity and Outcomes of Minimally Invasive Major Hepatectomies 58
Comparative Analysis of Left- Versus Right-sided Resection in Klatskin Tumor Surgery: can Lesion Side be Considered a Prognostic Factor? 58
The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE 57
Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT 57
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 56
Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 56
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 56
Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation 56
Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible 55
Predicting the need for step-up after EUS-guided drainage of peripancreatic fluid collections, including Quadrant-Necrosis-Infection score validation: A prospective cohort study 55
Complications after percutaneous transaxillary implantation of a catheter for intraarterial chemotherapy of liver tumors: clinical relevance and management in 204 patients 55
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 55
Biliary cystadenoma: short- and long-term outcome after radical hepatic resection 55
Bioritmo ph-metrico della secrezione gastrica 55
Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases 55
Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria 55
Correlation Between Type of Retrieval Incision and Postoperative Outcomes in Laparoscopic Liver Surgery: A Critical Assessment 55
Cholangiocarcinoma: new perspectives for new horizons 55
EUS-GUIDED GASTROENTEROSTOMY FOR MANAGEMENT OF MALIGNANT GASTRIC OUTLET OBSTRUCTION: A PROSPECTIVE SERIES FROM THE PROTECT REGISTRY 54
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 54
Long-term oncological outcomes after laparoscopic parenchyma-sparing redo liver resections for patients with metastatic colorectal cancer: a European multi-center study 54
An International Retrospective Observational Study of Liver Functional Deterioration after Repeat Liver Resection for Patients with Hepatocellular Carcinoma 54
Impact of liver cirrhosis, severity of cirrhosis and portal hypertension on the difficulty of laparoscopic and robotic minor liver resections for primary liver malignancies in the anterolateral segments 54
Factors Associated with and Impact of Open Conversion in Laparoscopic and Robotic Minor Liver Resections: An International Multicenter Study of 10,541 Patients 53
Totale 9.060
Categoria #
all - tutte 297.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 297.840


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 12 2 5 0 2 2 1
2021/2022402 1 0 1 153 18 40 59 52 29 15 9 25
2022/20233.701 1.842 578 182 28 50 342 314 199 105 23 23 15
2023/20241.498 39 31 119 95 96 177 55 111 7 95 167 506
2024/202512.456 1.613 325 142 155 267 986 1.642 1.081 2.370 1.904 875 1.096
2025/202620.038 2.611 3.697 4.689 6.017 2.787 237 0 0 0 0 0 0
Totale 38.782